| $687M | ||
| $385M | ||
| $215M | ||
| $100M | ||
| $87M | ||
| $82M |
Buys | $4,000,440 | 1 | 100 |
Sells | $0 | 0 | 0 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | See Remarks | 1 | $4M | 0 | $0 | $4M |
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Over the last 12 months, insiders at TELA Bio, Inc. have bought $4M and sold $0 worth of TELA Bio, Inc. stock.
On average, over the past 5 years, insiders at TELA Bio, Inc. have bought $7.64M and sold $1.91M worth of stock each year.
Highest buying activity among insiders over the last 12 months: EW HEALTHCARE PARTNERS FUND 2, L.P. (See Remarks) — $4M.
The last purchase of 3,604,000 shares for transaction amount of $4M was made by EW HEALTHCARE PARTNERS FUND 2, L.P. (See Remarks) on 2025‑11‑17.
| 2025-11-17 | EW HEALTHCARE PARTNERS FUND 2, L.P. | See Remarks | 3.6M 8.8578% | $1.11 | $4M | 0.00% | ||
| 2024-10-24 | KOBLISH ANTONY | Chief Executive Officer | 88,888 0.325% | $2.25 | $199,998 | -26.55% | ||
| 2024-10-24 | Cuca Roberto | COO and CFO | 64,444 0.2356% | $2.25 | $144,999 | -26.55% | ||
| 2024-10-24 | Talmo Paul | Chief Technology Officer | 22,222 0.0813% | $2.25 | $50,000 | -26.55% | ||
| 2024-10-24 | Firestone Gregory A. | Chief Commercial Officer | 6,666 0.0244% | $2.25 | $14,999 | -26.55% | ||
| 2024-07-02 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 36,600 0.1299% | $4.54 | $166,164 | -42.52% | |
| 2024-07-01 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 13,700 0.0501% | $4.68 | $64,116 | -40.98% | |
| 2024-06-28 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 378,000 1.4002% | $4.74 | $1.79M | -43.62% | |
| 2023-12-05 | Firestone Gregory A. | Chief Business Officer | 2,600 0.011% | $5.65 | $14,688 | -9.72% | ||
| 2023-11-14 | KOBLISH ANTONY | Chief Executive Officer | 11,000 0.0454% | $4.54 | $49,976 | +9.47% | ||
| 2023-11-14 | Cuca Roberto | COO and CFO | 10,000 0.0408% | $4.49 | $44,938 | +9.47% | ||
| 2023-04-21 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 27,700 0.1432% | $9.41 | $260,657 | -24.76% | |
| 2023-04-20 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 28,300 0.1502% | $9.43 | $266,869 | -22.68% | |
| 2023-04-19 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 136,000 0.7142% | $9.30 | $1.26M | -22.32% | |
| 2022-11-03 | Opaleye Management Inc. | director | 20,262 0.1236% | $7.81 | $158,285 | +26.43% | ||
| 2022-10-11 | Opaleye Management Inc. | director | 16,000 0.0971% | $8.00 | $128,000 | +22.84% | ||
| 2022-08-17 | EW Healthcare Partners Fund 2-UGP, LLC | 500,000 2.8654% | $8.00 | $4M | +19.45% | |||
| 2022-08-16 | Opaleye Management Inc. | 15,000 0.0881% | $8.00 | $120,000 | +22.39% | |||
| 2022-08-10 | Opaleye Management Inc. | 11,500 0.0684% | $8.52 | $98,006 | +16.37% | |||
| 2022-08-01 | Opaleye Management Inc. | 10 percent owner | 4,979 0.0296% | $7.96 | $39,632 | +24.38% |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | See Remarks | 7714709 19.1355% | $9.1M | 118 | 0 | +1.91% |
| EW Healthcare Partners Fund 2-UGP, LLC | 4105709 10.1838% | $4.84M | 25 | 0 | +12.99% | |
| ORBIMED ADVISORS LLC | 10 percent owner | 2407242 5.9709% | $2.84M | 1 | 6 | +2.92% |
| Opaleye Management Inc. | director | 1948000 4.8318% | $2.3M | 10 | 0 | +27.85% |
| RTW INVESTMENTS, LP | 10 percent owner | 1139358 2.8261% | $1.34M | 1 | 1 | +23.06% |
| Oliva Adele C | 888664 2.2042% | $1.05M | 1 | 0 | +2.92% | |
| Quaker BioVentures II LP | 10 percent owner | 888664 2.2042% | $1.05M | 1 | 0 | +2.92% |
| KOBLISH ANTONY | Chief Executive Officer | 458897 1.1382% | $541,498.46 | 2 | 0 | <0.0001% |
| Zuga Matt | director | 260808 0.6469% | $307,753.44 | 1 | 0 | +2.92% |
| Azarbarzin Kurt | director | 260808 0.6469% | $307,753.44 | 1 | 0 | +2.92% |
| Cuca Roberto | COO and CFO | 155388 0.3854% | $183,357.84 | 7 | 0 | <0.0001% |
| Talmo Paul | Chief Technology Officer | 91082 0.2259% | $107,476.76 | 1 | 0 | <0.0001% |
| Firestone Gregory A. | Chief Commercial Officer | 57279 0.1421% | $67,589.22 | 2 | 0 | <0.0001% |
| Increased Positions | 11 | +20.75% | 561,497 | +2.39% |
| Decreased Positions | 17 | -32.08% | 473,929 | -2.02% |
| New Positions | <1 | New | 35,281 | New |
| Sold Out Positions | 7 | Sold Out | 132,417 | Sold Out |
| Total Postitions | 47 | -11.32% | 24M | +0.37% |
| Nantahala Capital Management, Llc | $5,878.00 | 11.36% | 5.11M | 0 | 0% | 2025-09-30 |
| Essex Woodlands Management, Inc. | $4,727.00 | 9.14% | 4.11M | 0 | 0% | 2025-09-30 |
| Silverarc Capital Management, Llc | $3,200.00 | 6.18% | 2.78M | +3,128 | +0.11% | 2025-09-30 |
| Stonepine Capital Management, Llc | $2,479.00 | 4.79% | 2.16M | +71,757 | +3.44% | 2025-09-30 |
| Vanguard Group Inc | $2,070.00 | 4% | 1.8M | -111,694 | -5.84% | 2025-09-30 |
| Dafna Capital Management Llc | $1,657.00 | 3.2% | 1.44M | 0 | 0% | 2025-09-30 |
| Perkins Capital Management Inc | $959.00 | 1.85% | 833,928 | -41,937 | -4.79% | 2025-09-30 |
| Citigroup Inc | $863.00 | 1.67% | 750,000 | 0 | 0% | 2025-09-30 |
| Velan Capital Investment Management Lp | $860.00 | 1.66% | 747,410 | 0 | 0% | 2025-09-30 |
| Pentwater Capital Management Lp | $834.00 | 1.61% | 724,856 | -90,144 | -11.06% | 2025-09-30 |